Researchers have converted the CRISPR ‘recognition induced enzymatic signal’ to an electrical signal, which was then used to detect the biomarkers for viruses such as HPV or parvo. They hope the end result could be a new ‘universal biosensing’ point-of-care medical device — similar to the existing commercial blood-glucose sensor — that rapidly and accurately detects those viruses and more.